miltefosine has been researched along with Carcinoma, Renal Cell in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Settelen, N | 1 |
| Roch, O | 1 |
| Bock, D | 1 |
| Rooke, R | 1 |
| Braun, S | 1 |
| Meyer, O | 1 |
1 other study available for miltefosine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Controlled plasmid gene transfer to murine renal carcinoma by hexadecylphosphocholine.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Delayed-Action Preparations; Dose-Response Relatio | 2004 |